Acidosis–GPR4 signaling induces endothelial adhesion molecules and broad inflammatory gene programs via cAMP/EPAC → NF-κB; small-molecule GPR4 antagonists suppress these responses in vitro, nominating GPR4 as a druggable node of acid-driven inflammation [62,63]. The gene discussed is GPR4; the disease is acidosis disorder.